Investitionsthese
Hikma Ventures invests in healthcare and life sciences businesses where Hikma’s expertise and global presence can support growth; it is stage-agnostic and prefers Series A and later.
Investitionsphase
Series A and beyond (stage-agnostic)
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Drug Delivery, Digital Therapeutics, Clinical Trial Innovation, Respiratory, CNS, Oncology, Autoimmune Diseases, Chronic Diseases (Type II Diabetes, hypertension), Overdose and Abuse solutions
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
k.A.
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (9)
A
Ahmad Fayyad
Principal
A
Ali Al-Husry
Non-Executive Director
B
Bassam Kanaan
EVP, Corporate Development and M&A
C
Cynthia Flowers
Independent Non-Executive Director
D
Deneen Vojta
Independent Non-Executive Director
H
Haya Khoury
Analyst
L
Lana Ghanem
Managing Director
M
Mazen Darwazah
Executive Vice Chairman, President of MENA
S
Salma Al-Zu'bi
Principal
